Pharmacoeconomic Evaluation of Tegafur Gimeracil and Oteracil Porassium in the Treatment of Unresectable Metastatic Colorectal Cancer

Liang Xin, Ning Xiao, Ding Ying, Zhang Mengqi, Xiao Yan, Geng Xiaokun

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (4) : 471-478.

PDF(1247 KB)
PDF(1247 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (4) : 471-478. DOI: 10.16153/j.1002-7777.2025-01-0030
Hospital Pharmacy

Pharmacoeconomic Evaluation of Tegafur Gimeracil and Oteracil Porassium in the Treatment of Unresectable Metastatic Colorectal Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(4): 471-478 https://doi.org/10.16153/j.1002-7777.2025-01-0030

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1247 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉